Sonora Investment Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.36M Sell
3,095
-125
-4% -$93K 0.17% 93
2025
Q2
$2.51M Buy
3,220
+170
+6% +$132K 0.19% 92
2025
Q1
$2.52M Buy
3,050
+127
+4% +$106K 0.2% 92
2024
Q4
$2.26M Sell
2,923
-42
-1% -$34.8K 0.17% 100
2024
Q3
$2.63M Buy
2,965
+553
+23% +$497K 0.19% 95
2024
Q2
$1.88M Hold
2,412
0.15% 114
2024
Q1
$1.88M Buy
2,412
+89
+4% +$63.3K 0.15% 114
2023
Q4
$1.35M Sell
2,323
-1
-0% -$584 0.11% 120
2023
Q3
$1.25M Buy
2,324
+191
+9% +$98.4K 0.11% 129
2023
Q2
$1M Sell
2,133
-118
-5% -$49.5K 0.08% 135
2023
Q1
$773K Sell
2,251
-303
-12% -$102K 0.07% 147
2022
Q4
$935K Buy
2,554
+171
+7% +$60.6K 0.09% 137
2022
Q3
$773K Hold
2,383
0.1% 114
2022
Q2
$773K Buy
2,383
+70
+3% +$21K 0.07% 145
2022
Q1
$663K Hold
2,313
0.08% 122
2021
Q4
$639K Buy
+2,313
New +$586K 0.07% 121

Other funds holding LLY

Sonora Investment Management Group's LLY Position: Q3 2025 in Review

Sonora Investment Management Group reduced its Eli Lilly (LLY) stake by 3.9% in Q3 2025, selling an estimated $93K and leaving 3,095 shares worth $2.36M. The position accounts for 0.17% of the portfolio, ranked #93.

Sonora Investment Management Group first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.63M in Q3 2024. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Sonora Investment Management Group held 3,095 shares of Eli Lilly worth $2.36M as of Q3 2025.
  • Sonora Investment Management Group sold 125 Eli Lilly shares in Q3 2025, an estimated $93K.
  • Eli Lilly made up 0.17% of Sonora Investment Management Group's portfolio in Q3 2025, its #93 holding.
  • Sonora Investment Management Group first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
  • Sonora Investment Management Group's Eli Lilly position peaked at $2.63M in Q3 2024.
  • 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.